月期刊平台服务过的文章录用时间为1-3个月，依据20年经验，经月期刊专家预审通过后的文章，投稿通过率100%以上！
肿瘤发表在所有肿瘤研究领域的新研究结果。选择“肿瘤”这个标题来传达期刊的广度，它涵盖了癌症研究的传统学科以及新兴领域和跨学科研究。肿瘤病对描述与肿瘤表型相关的新分子和遗传发现的研究以及实验室和临床研究感兴趣，这些研究显示了基础科学在风险评估、预后适应症、检测、诊断和治疗方面的创新应用。除了定期的研究报告，肿瘤也发表评论和会议报告。肿瘤病致力于确保一个全面、公平、快速的审查和出版时间表，通过传播癌症研究中的重要数据和观点，进一步促进其为科学界和临床界服务的使命。肿瘤鼓励自由交换其页面中描述的所有克隆、细胞系和生物试剂，以促进研究进展，最终为那些对抗肿瘤疾病的人们提供新的诊断、预防和治疗选择。
http://ees.elsevier.com/neo
Neoplasia publishes the results of novel investigations in all areas of oncology research. The title Neoplasia was chosen to convey the journals breadth, which encompasses the traditional disciplines of cancer research as well as emerging fields and interdisciplinary investigations. Neoplasia is interested in studies describing new molecular and genetic findings relating to the neoplastic phenotype and in laboratory and clinical studies demonstrating creative applications of advances in the basic sciences to risk assessment, prognostic indications, detection, diagnosis, and treatment. In addition to regular Research Reports, Neoplasia also publishes Reviews and Meeting Reports. Neoplasia is committed to ensuring a thorough, fair, and rapid review and publication schedule to further its mission of serving both the scientific and clinical communities by disseminating important data and ideas in cancer research.Neoplasia encourages the free exchange of all clones, cell lines, and biological reagents described in its pages to facilitate the progress of research in order to ultimately provide those fighting neoplastic diseases with new diagnostic, preventative and therapeutic options.
